Key points are not available for this paper at this time.
Glioblastoma is the most common and aggressive malignant primary brain tumor. Cellular heterogeneity is a characteristic feature of the disease and contributes to the difficulty in formulating effective therapies. Glioma stem-like cells (GSCs) have been identified as a subpopulation of tumor cells that are thought to be largely responsible for resistance to treatment. Intratumoral hypoxia contributes to maintenance of the GSCs by supporting the critical stem cell traits of multipotency, self-renewal, and tumorigenicity. This review highlights the interaction of GSCs with the hypoxic tumor microenvironment, exploring the mechanisms underlying the contribution of GSCs to tumor vessel dynamics, immune modulation, and metabolic alteration.
Building similarity graph...
Analyzing shared references across papers
Loading...
Colwell et al. (Tue,) studied this question.
synapsesocial.com/papers/69e88b60c8a7fe3f9324b7ee — DOI: https://doi.org/10.1093/neuonc/now258
Nicole Colwell
Association of Community Cancer Centers
Mioara Larion
National Institutes of Health
Amber Giles
Boston University
Neuro-Oncology
National Cancer Institute
National Institute of Neurological Disorders and Stroke
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: